Achieving an itch-free state with Upadacitinib: a post-hoc analysis of data from the Phase 2b randomized, doubleblind, placebo-controlled trial in moderate-to-severe atopic dermatitis

被引：0
|
作者：
Silverberg, J. [1 ]
Reich, K. [2 ,3 ]
Calimlim, B., III [4 ]
Gu, Y. [4 ]
Hu, X. [4 ]
Teixera, H. [4 ]
Guttman-Yassky, E. [5 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Dermatologikum Berlin, Hamburg, Germany
[3] SCIderm Res Inst, Hamburg, Germany
[4] AbbVie Inc, N Chicago, IL USA
[5] Mt Sinai Med Ctr, Icahn Sch Med, New York, NY 10029 USA
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2020年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P080
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [31] <show/>Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials<show/>
    Yosipovitch, Gil
    Lio, Peter A.
    Rosmarin, David
    Serra-Baldrich, Esther
    Legat, Franz J.
    Casillas, Marta
    Pierce, Evangeline
    Liu, Zhuqing
    Sun, Luna
    Elmaraghy, Hany
    Staender, Sonja
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (02) : 289 - 291
  • [32] DUPILUMAB TREATMENT REDUCES HOSPITALIZATIONS IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POOLED ANALYSIS OF DATA FROM 7 RANDOMIZED, PLACEBO-CONTROLLED STUDIES
    Silverberg, J.
    Rubini, N.
    Pires, M. C.
    Rossi, A.
    Zhang, A.
    Chen, Z.
    Levit, N. A.
    Thomas, R.
    Shumel, B.
    Bego, G.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S20 - S20
  • [33] Dupilumab treatment reduces hospitalizations in adults with moderate-to-severe atopic dermatitis: a pooled analysis of data from seven randomized, placebo-controlled studies
    Rubini, N. P. M.
    Silverberg, J. I.
    Pires, M. C.
    Chen, Z.
    Chao, J.
    Bego-Le Bagousse, G.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E116 - E117
  • [34] A phase 2b, randomized, double-blind, placebo-controlled, global study to evaluate the efficacy and safety of ANB032 in the treatment of moderate-to-severe atopic dermatitis
    Ehst, B.
    Silverberg, J.
    Lizzul, P.
    Luu, K.
    Papacharalambous, J.
    Raina, P.
    Randazzo, B.
    Sibley, C.
    Guttman-Yassky, E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S347 - S347
  • [35] Worsening of itch before flaring in patients with moderate-to-severe atopic dermatitis treated with abrocitinib: a post hoc analysis of the phase 3 JADE REGIMEN trial
    Silverberg, Jonathan, I
    Kim, Brian S.
    de Bruin-Weller, Marjolein
    Weidinger, Stephan
    Steinhoff, Martin
    Biswas, Pinaki
    Kerkmann, Urs
    Feeney, Claire
    Koppensteiner, Herwig
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II31 - II32
  • [36] Tralokinumab provides progressive and sustained efficacy in adolescents with moderate-to-severe atopic dermatitis: a post-hoc analysis of the ECZTRA 6 trial
    Simpson, Eric L.
    Wollenberg, Andreas
    Kurbasic, Azra
    Tindberg, Ann-Marie
    Soldbro, Lise
    Paller, Amy S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [37] Dupilumab offers rapid improvement in pruritus in adolescents with moderate-to-severe atopic dermatitis vs placebo: a post hoc analysis of a phase III trial
    Simpson, E. L.
    Gadkari, A.
    Beck, L. A.
    Hong, H. C. H.
    Bansal, A.
    Chen, Z.
    Mina-Osorio, P.
    Prescilla, R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E94 - E95
  • [38] Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial
    Guttman-Yassky, E.
    Bahadori, L.
    Brooks, L.
    Clark, K. L.
    Grindebacke, H.
    Ho, C. N.
    Katial, R.
    Pham, T. -H.
    Walton, C.
    Datto, C. J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) : E1211 - E1214
  • [39] Efficacy and Safety of Lebrikizumab in Combination with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 3, Randomized, Placebo-Controlled Trial (ADhere)
    Simpson, Eric L.
    Gooderham, Melinda
    Wollenberg, Andreas
    Weidinger, Stephan
    Armstrong, April
    Soung, Jennifer
    Ferrucci, Silvia
    Lima, Renata Gontijo
    Xu, Wen
    Witte, Michael M.
    Blauvelt, Andrew
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 61 - 61
  • [40] Efficacy and safety of lebrikizumab in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis: a phase III randomized, placebo-controlled trial (ADhere)
    Simpson, Eric L.
    Gooderham, Melinda
    Wollenberg, Andreas
    Weidinger, Stephan
    Armstrong, April
    Soung, Jennifer
    Ferrucci, Silvia
    Lima, Renata Gontijo
    Xu, Wen
    Witte, Michael M.
    Blauvelt, Andrew
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E108 - E108
12345